DTE vs IMCR
DTE (DTE) versus Immunocore Holdings Ltd (IMCR) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
DTE does not have a complete income-statement cache yet.
Latest reported IMCR revenue for 2024-12-31 was $310.2M. Net income was -$51.1M. Revenue was up 24.4% from 2023-12-31 to 2024-12-31. IMCR currently screens at market cap $1.45B.
DTE currently screens at market cap $0. IMCR currently screens at market cap $1.45B.
Not investment advice. Open the DTE and IMCR stock pages for the full models.
Not investment advice.